Spots Global Cancer Trial Database for Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
Official Title: Randomized Trial of Epoetin Alfa in Patients With Advanced Non-Small Cell Carcinoma of the Lung (EPO-CAN-20)
Study ID: NCT00310232
Interventions
Study Description
Brief Summary: The general objective of this study is to improve the Quality of Life (QoL) of selected patients with advanced carcinoma of the lung. The specific objective is to evaluate the effect of treatment with epoetin alfa (recombinant human erythropoietin) on anemia related QoL and anemia in non-small cell lung cancer patients with advanced stage disease and underlying anemia of malignancy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Cross Cancer Institute, Edmonton, Alberta, Canada
Cancer Care Manitoba, Winnipeg, Manitoba, Canada
St. John Regional Hospital, St. John, New Brunswick, Canada
Newfoundland Cancer Treatment & Research Foundation, St. John's, Newfoundland and Labrador, Canada
Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada
Hamilton Regional Cancer Centre (Juravinski), Hamilton, Ontario, Canada
London Regional Cancer Centre, London, Ontario, Canada
Hotel Dieu Hospital, St. Catherines, Ontario, Canada
Northeastern Ontario Regional Cancer Centre, Sudbury, Ontario, Canada
Toronto East General Hospital, Toronto, Ontario, Canada
Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada
Princess Margaret Hospital, Toronto, Ontario, Canada
Windsor Regional Cancer Centre, Windsor, Ontario, Canada
McGill University Clinical Trials Operations, Montreal, Quebec, Canada
Contact Details
Name: Jim Wright, MD
Affiliation: Hamilton Regional Cancer Centre
Role: STUDY_CHAIR
Name: Mark Levine, MD
Affiliation: Ontarion Clinical Oncology Group
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
